668
Views
10
CrossRef citations to date
0
Altmetric
EXTRA VIEW

Prion diseases and adult neurogenesis: How do prions counteract the brain's endogenous repair machinery?

, &
Pages 240-246 | Received 24 Mar 2014, Accepted 25 Apr 2014, Published online: 01 Nov 2014

References

  • Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519-50; PMID:11283320; http://dx.doi.org/10.1146/annurev.neuro.24.1.519
  • Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337-48; PMID:9590169; http://dx.doi.org/10.1016/S0092–8674(00)81163–0
  • Bouzamondo-Bernstein E, Hopkins SD, Spilman P, Uyehara-Lock J, Deering C, Safar J, Prusiner SB, Ralston HJ 3rd, DeArmond SJ. The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol 2004; 63:882-99; PMID:15330342
  • Mallucci G, Collinge J. Rational targeting for prion therapeutics. Nat Rev Neurosci 2005; 6:23-34; PMID:15611724; http://dx.doi.org/10.1038/nrn1584
  • Brown KL, Brown J, Ritchie DL, Sales J, Fraser JR. Fetal cell grafts provide long-term protection against scrapie induced neuronal loss. Neuroreport 2001; 12:77-82; PMID:11201096; http://dx.doi.org/10.1097/00001756–200101220–00023
  • Relaño-Ginés A, Lehmann S, Bencsik A, Herva ME, Torres JM, Crozet CA. Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner. J Infect Dis 2011; 204:1038-45; PMID:21881119; http://dx.doi.org/10.1093/infdis/jir484
  • Relaño-Ginés A, Gabelle A, Lehmann S, Milhavet O, Crozet C. Gene and cell therapy for prion diseases. Infect Disord Drug Targets 2009; 9:58-68; PMID:19200016; http://dx.doi.org/10.2174/1871526510909010058
  • Crozet C, Lin YL, Mettling C, Mourton-Gilles C, Corbeau P, Lehmann S, Perrier V. Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations. J Cell Sci 2004; 117:5591-7; PMID:15494372; http://dx.doi.org/10.1242/jcs.01484
  • Toupet K, Compan V, Crozet C, Mourton-Gilles C, Mestre-Francés N, Ibos F, Corbeau P, Verdier JM, Perrier V. Effective gene therapy in a mouse model of prion diseases. PLoS One 2008; 3:e2773; PMID:18648643; http://dx.doi.org/10.1371/journal.pone.0002773
  • Cameron HA, McKay RD. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 2001; 435:406-17; PMID:11406822; http://dx.doi.org/10.1002/cne.1040
  • Taupin P, Gage FH. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J Neurosci Res 2002; 69:745-9; PMID:12205667; http://dx.doi.org/10.1002/jnr.10378
  • Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci 2002; 22:629-34; PMID:11826091
  • Gage FH. Mammalian neural stem cells. Science 2000; 287:1433-8; PMID:10688783; http://dx.doi.org/10.1126/science.287.5457.1433
  • Kempermann G, Wiskott L, Gage FH. Functional significance of adult neurogenesis. Curr Opin Neurobiol 2004; 14:186-91; PMID:15082323; http://dx.doi.org/10.1016/j.conb.2004.03.001
  • Ruan L, Lau BW, Wang J, Huang L, Zhuge Q, Wang B, et al. Neurogenesis in neurological and psychiatric diseases and brain injury: From bench to bedside. Prog Neurobiol 2014; 115:116-37; PMID:24384539
  • Cayre M, Canoll P, Goldman JE. Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol 2009; 88:41-63; PMID:19428961; http://dx.doi.org/10.1016/j.pneurobio.2009.02.001
  • Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002; 8:963-70; PMID:12161747; http://dx.doi.org/10.1038/nm747
  • Jin K, Sun Y, Xie L, Peel A, Mao XO, Batteur S, Greenberg DA. Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci 2003; 24:171-89; PMID:14550778; http://dx.doi.org/10.1016/S1044–7431(03)00159–3
  • Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, Greenberg DA. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 2004; 101:343-7; PMID:14660786; http://dx.doi.org/10.1073/pnas.2634794100
  • Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ, Dragunow M, Connor B, Faull RL. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A 2003; 100:9023-7; PMID:12853570; http://dx.doi.org/10.1073/pnas.1532244100
  • Chevallier NL, Soriano S, Kang DE, Masliah E, Hu G, Koo EH. Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am J Pathol 2005; 167:151-9; PMID:15972961; http://dx.doi.org/10.1016/S0002–9440(10)62962–8
  • Mehler MF, Gokhan S. Developmental mechanisms in the pathogenesis of neurodegenerative diseases. Prog Neurobiol 2001; 63:337-63; PMID:11115729; http://dx.doi.org/10.1016/S0301–0082(00)00052–6
  • Cronier S, Carimalo J, Schaeffer B, Jaumain E, Béringue V, Miquel MC, Laude H, Peyrin JM. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death. FASEB J 2012; 26:3854-61; PMID:22661006; http://dx.doi.org/10.1096/fj.11–201772
  • Steele AD, Emsley JG, Ozdinler PH, Lindquist S, Macklis JD. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci U S A 2006; 103:3416-21; PMID:16492732; http://dx.doi.org/10.1073/pnas.0511290103
  • Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007; 1772:629-44; PMID:17451912; http://dx.doi.org/10.1016/j.bbadis.2007.02.011
  • Pradines E, Hernandez-Rapp J, Villa-Diaz A, Dakowski C, Ardila-Osorio H, Haik S, Schneider B, Launay JM, Kellermann O, Torres JM, et al. Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance. Cell Death Dis 2013; 4:e456; PMID:23303130; http://dx.doi.org/10.1038/cddis.2012.195
  • Simon D, Herva ME, Benitez MJ, Garrido JJ, Rojo AI, Cuadrado A, et al. Dysfunction of the PI3K-Akt-GSK-3 pathway is a common feature in cell culture and in vivo models of prion disease. Neuropathol Appl Neurobiol 2014; 40:311-26; PMID:23741998
  • Relaño-Ginès A, Gabelle A, Hamela C, Belondrade M, Casanova D, Mourton-Gilles C, Lehmann S, Crozet C. Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases. PLoS Pathog 2013; 9:e1003485; PMID:23935493; http://dx.doi.org/10.1371/journal.ppat.1003485
  • Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 2002; 83:1509-24; PMID:12472904; http://dx.doi.org/10.1046/j.1471–4159.2002.01267.x
  • Lee YJ, Baskakov IV. The cellular form of the prion protein is involved in controlling cell cycle dynamics, self-renewal, and the fate of human embryonic stem cell differentiation. J Neurochem 2013; 124:310-22; PMID:22860629; http://dx.doi.org/10.1111/j.1471–4159.2012.07913.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.